Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 12, 2014, Pages E2652-E2660

  Jayasena, C N ^a   Abbara, A ^a   Izzi Engbeaya, C ^a   Comninos, A N ^a   Harvey, R A ^c   Gonzalez Maffe, J ^b   Sarang, Z ^a   Ganiyu Dada, Z ^a   Padilha, A I ^c   Dhanjal, M ^d   Williamson, C ^e   Regan, L ^f   Ghatei, M A ^a   Bloom, S R ^a   Dhillo, Waljit S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; KISSPEPTIN;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; DOWN REGULATION; FEMALE; GESTATIONAL AGE; GONADOTROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PRENATAL CARE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING HABIT; SPONTANEOUS ABORTION; TERTIARY CARE CENTER; TWIN PREGNANCY; ABORTION, SPONTANEOUS; BLOOD; COHORT ANALYSIS; FIRST TRIMESTER PREGNANCY; PREGNANCY; RISK;

ABORTION, SPONTANEOUS; ADULT; CHORIONIC GONADOTROPIN; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; KISSPEPTINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; PROSPECTIVE STUDIES; RISK;

EID: 84916620154     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1953     Document Type: Article

References (30)

1. Royal College of Obstetricians and Gynaecologists. The Management of Early Pregnancy Loss. Green-top Guideline Number 25. London: Royal College of Obstetricians and Gynaecologists; 2006.
2. Alberman E. Spontaneous abortion: epidemiology. In: Stabile S, Grudzinkas G, Chard T, eds. Spontaneous Abortion: Diagnosis and Treatment. London: Springer-Verlag;1992:9-20.
3. Ammon Avalos L, Galindo C, Li DK. A systematic review to calculate background miscarriage rates using life table analysis. Birth Defects Res A Clin Mol Teratol. 2012;94:417-423.
4. Lee C, Slade P. Miscarriage as a traumatic event: a review of the literature and new implications for intervention. J Psychosom Res. 1996;40:235-244.
5. Buchmayer SM, Sparen P, Cnattingius S. Previous pregnancy loss: risks related to severity of preterm delivery. Am J Obstet Gynecol. 2004;191:1225-1231.
6. Bhattacharya S, Townend J, Shetty A, Campbell D, Bhattacharya S. Does miscarriage in an initial pregnancy lead to adverse obstetric and perinatal outcomes in the next continuing pregnancy? Br J Obstet Gynecol. 2008;115:1623-1629.
7. van Oppenraaij RHF, Jauniaux E, Christiansen OB, Horcajadas JA, Farquharson RG, Exalto N. ESHRESpecial Interest Group for Early Pregnancy (SIGEP). Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Hum Reprod Upd. 2009;15:409-421.
8. Alberman ED, Creasy MR. Frequency of chromosomal abnormalities in miscarriages and perinatal deaths. J Med Genet. 1977;14:313-315.
9. Horne AW, McBride R, Denison FC. A normally rising hCG does not predict live birth in women presenting with pain and bleeding in early pregnancy. Eur J Obstet Gynecol Reprod Biol. 2011;156:120-121.
10. Hustin J, Jauniaux E, Schaaps JP. Histological study of the maternoembryonic interface in spontaneous abortion. Placenta. 1990;11:477-486.
11. Jauniaux E, Zaidi J, Jurkovic D, Campbell S, Hustin J. Comparison of colour Doppler features and pathological findings in complicated early pregnancy. Hum Reprod. 1994;9:2432-2437.
12. Clements MK, McDonald TP, Wang R, et al. FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun. 2001;285:1189-1193.
13. Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276:34631-34636.
14. Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411:613-617.
15. Muir AI, Chamberlain L, Elshourbagy NA, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001;276:28969-28975.
16. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci. 2004;117:1319-1328.
17. Roseweir AK, Katz AA, Millar RP. Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3β-FAK feedback loop in HTR8SVneo cells. Placenta. 2012;33:408-415.
18. Horikoshi Y, Matsumoto H, Takatsu Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88:914-919.
19. Logie JJ, Denison FC, Riley SC, et al. Evaluation of kisspeptin levels in obese pregnancy as a biomarker for pre-eclampsia. Clin Endocrinol (Oxf). 2012;76:887-893.
20. Smets EM, Deurloo KL, Go AT, van Vugt JM, Blankenstein MA, Oudejans CB. Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates. Prenat Diagn. 2008;28:299-303.
21. Park D-W, Lee S-K, Hong SR, Han A-R, Kwak-Kim J, Yang KM. Expression of kisspeptin and its receptor GPR 54 in the first trimester trophoblast of women with recurrent pregnancy loss. Am J Reprod Immunol. 2012;67:132-139.
22. Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis inhumanmales. J Clin Endocrinol Metab. 2005;90:6609-6615.
23. Dhillo WS, Chaudhri OB, Thompson EL, et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab. 2007;92:3958-3966.
24. st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem. 2009;55:1484-1491.
25. Harvey RA, Mitchell HD, Stenman UH, et al. Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors. J Reprod Med. 2010;55:285-295.
26. Seeber BE. What serial hCG can tell you, and cannot tell you, about an early pregnancy. Fertil Steril. 2012;98:1074-1077.
27. Alfthan H, Schroder J, Fraser R, Koskimies A, Halila H, Stenman UH. Choriogonadotropin and its beta subunit separated by hydro-phobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem. 1988;34:1758-1762.
28. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage. NICE guideline (CG154). London: National Institute for Health and Care Excellence; 2012.
29. Armstrong RA, Reynolds RM, Leask R, Shearing CH, Calder AA, Riley SC. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagn. 2009;29:982-985.
30. Kavvasoglu S, Ozkan ZS, Kumbak B, Simsek M, Ilhan N. Association of kisspeptin-10 levels with abortus imminens: a preliminary study. Arch Gynecol Obstet. 2012;285:649-653.